Home > Boards > US OTC > Medical - Drugs > Creative Medical Technology Holdings Inc. (CELZ)

In addition, for those who would assert that

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
uvaphd Member Profile
 
Followed By 8
Posts 2,846
Boards Moderated 0
Alias Born 05/09/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 4:06:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 4:06:19 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2020 4:36:39 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/6/2020 4:03:35 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 3/30/2020 4:02:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/24/2020 4:03:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/19/2020 6:05:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/19/2020 6:04:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2020 4:03:32 PM
Information Statement (definitive, Revised) (defr14c) Edgar (US Regulatory) - 1/3/2020 4:02:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/13/2019 4:06:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/13/2019 4:05:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/13/2019 4:03:30 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 11/22/2019 4:50:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:49:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 6:40:49 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 11/5/2019 4:59:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/16/2019 4:03:28 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 9/13/2019 4:46:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 4:02:24 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 8/30/2019 4:02:45 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 4:49:40 PM
uvaphd   Sunday, 08/02/20 09:28:56 AM
Re: uvaphd post# 101991
Post # of 102046 
In addition, for those who would assert that the use of “LLC” with CaverStem need only occur at the first mention of the entity in June 2018 (the comparative data for “Amniostem LLC” and “StemSpine LLC,” showing a VERY different pattern, notwithstanding), behold the following from the 2018 Annual Report, filed in early 2019:

"In June 2018, we formed CaverStem International, LLC, in Nevada for the purpose of licensing the CaverStem procedure internationally. This entity is 60% owned by Creative Medical Technology Holdings, Inc. and 40% owned by Dr. Alex Gershman. It has not commenced any business activities."

https://www.marketwatch.com/investing/Stock/celz/SecFilings?subview=secarticle&sid=3735993&guid=13335603&type=1


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist